Virax Biolabs Group (NASDAQ:VRAX) Versus Lucira Health (NASDAQ:LHDXQ) Head to Head Contrast
Virax Biolabs Group (NASDAQ:VRAX) Versus Lucira Health (NASDAQ:LHDXQ) Head to Head Contrast
Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Lucira Health (NASDAQ:LHDXQ – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.
Virax Biolabs Group（納斯達克股票代碼：VRAX — 獲取評級）和 Lucira Health（納斯達克股票代碼：LHDXQ — 獲取評級）都是小型醫療公司，但哪家企業更好？我們將根據兩家企業的風險實力、估值、分析師建議、股息、機構所有權、盈利能力和收益對比這兩家企業。
Profitability
盈利能力
This table compares Virax Biolabs Group and Lucira Health's net margins, return on equity and return on assets.
該表比較了Virax Biolabs集團和Lucira Health的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Virax Biolabs Group | N/A | N/A | N/A |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| Virax Biolabs 集團 | 不適用 | 不適用 | 不適用 |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
Valuation & Earnings
估值與收益
This table compares Virax Biolabs Group and Lucira Health's revenue, earnings per share (EPS) and valuation.
該表比較了Virax Biolabs Group和Lucira Health的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Virax Biolabs Group | $120,000.00 | 62.21 | -$1.71 million | N/A | N/A |
| Lucira Health | $93.06 million | 0.05 | -$64.83 million | ($3.58) | -0.04 |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| Virax Biolabs 集團 | 120,000.00 美元 | 62.21 | -171 萬美元 | 不適用 | 不適用 |
| 露西拉健康 | 9306 萬美元 | 0.05 | -6,483 萬美元 | (3.58 美元) | -0.04 |
Virax Biolabs Group has higher earnings, but lower revenue than Lucira Health.
Virax Biolabs Group的收益更高，但收入低於Lucira Health。
Analyst Ratings
分析師評級
This is a breakdown of current recommendations for Virax Biolabs Group and Lucira Health, as reported by MarketBeat.com.
據Marketbeat.com報道，這是目前對Virax Biolabs Group和Lucira Health的建議的明細。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Virax Biolabs Group | 0 | 0 | 0 | 0 | N/A |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| Virax Biolabs 集團 | 0 | 0 | 0 | 0 | 不適用 |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不適用 |
Institutional and Insider Ownership
機構所有權和內部所有權
0.5% of Virax Biolabs Group shares are owned by institutional investors. Comparatively, 57.0% of Lucira Health shares are owned by institutional investors. 45.1% of Virax Biolabs Group shares are owned by company insiders. Comparatively, 30.4% of Lucira Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Virax Biolabs集團的0.5％股份由機構投資者持有。相比之下，Lucira Health的股票中有57.0％由機構投資者持有。Virax Biolabs集團45.1％的股票由公司內部人士擁有。相比之下，Lucira Health的股份中有30.4％由公司內部人士持有。強大的機構所有權表明捐贈基金、大型基金經理和對沖基金認爲，從長遠來看，股票的表現將優於市場。
Summary
摘要
Virax Biolabs Group beats Lucira Health on 6 of the 8 factors compared between the two stocks.
Virax Biolabs Group在兩隻股票比較的8個因素中有6個擊敗了Lucira Health。
About Virax Biolabs Group
關於 Virax Biolabs 集團
(Get Rating)
（獲取評級）
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.
Virax Biolabs Group Limited是一家生物技術公司，銷售、分銷和銷售用於免疫學領域病毒性疾病的預防、檢測、診斷和風險管理的診斷檢測試劑盒以及醫療技術和個人防護裝備產品。該公司以 ViraxClear 品牌提供快速抗體 IgC/IgM 檢測、抗原檢測、聚合酶鏈反應快速檢測和中和抗體測試；以及醫療技術和個人防護用品，例如以 ViraxCare 品牌命名的員工防護設備產品，以及紅外溫度計、脈搏血氧計、口罩、手套和其他個人防護用品產品。它還分發霧化機器和智能可穿戴設備，提醒員工幫助他們遵守社交距離準則。此外，該公司還經營一個銷售ViraxClear和ViraxCare產品的在線平臺。它爲診所、藥房、實驗室、醫院和其他團體以及公司、員工、個人消費者、醫院系統以及公共和私人機構提供服務。該公司在歐洲、南美、亞太地區、撒哈拉以南非洲和國際上開展業務。該公司前身爲Virax Biolabs（開曼）有限公司，並於2021年9月更名爲Virax Biolabs Group Limited。Virax Biolabs Group Limited成立於2021年，總部位於英國倫敦。
About Lucira Health
關於 Lucira Health
(Get Rating)
（獲取評級）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家醫療技術公司。它專注於變革性和傳染病檢測試劑盒的開發和商業化。Lucira Health Inc. 總部位於加利福尼亞州的埃默裏維爾。
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收 Virax Biolabs Group 的新聞和收視率 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收Virax Biolabs Group及相關公司最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。